Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

SUPERVALU INC. (SVU) Jumps As It Considers Save-A-Lot Spinoff: Did Hedge Funds Foresee This?

The market is responding positively to SUPERVALU INC. (NYSE:SVU)’s announcement that it is considering spinning off Save-A-Lot into a separate publicly-traded company, as its stock is up to $8.69 per share earlier, up by 18.14% in early-afternoon trading. According to the firm, if it decides to split off Save-A-Lot, the two resulting independent firms will be able to better focus on growing their respective businesses. Save-A-Lot, a discount grocery chain, has over 1,300 locations, 430 of which are company-owned and 900 of which are franchises. In total the chain accounted for approximately 26% of SuperValu’s revenue in the first quarter. The news that SUPERVALU INC. (NYSE:SVU) is considering a spinoff of Save-A-Lot comes as SuperValu beat top and bottom line expectations in the company’s fiscal second quarter that ended on June 20. The firm reported net income attributable to SuperValu of $61 million or $0.23 per share, up by 42% year-on-year, on net sales of $5.41 billion, up by 2.7% compared to the year-ago quarter. Wall Street was expecting earnings of $0.20 per share on sales of $5.39 billion.

Inflation Food Prices

The SUPERVALU INC. (NYSE:SVU) spike today and its beat for the second quarter appears to be contrary to the bearishness of hedge funds in the first quarter. While it may seem that hedge funds were bullish in the maiden quarter of the year, as at the end of the first quarter, a total of 36 of the hedge funds tracked by Insider Monkey held long positions in this stock, up from 29 in the fourth quarter, the total value of their holdings went down by 8.57% quarter-on-quarter, to about $580 million, despite the stock soaring by nearly 20% from January 2 to March 31. Funds were certainly right in that sense, as shares crumbled by 30% in the second quarter.

Why are we interested in the 13F filings of a select group of hedge funds? We use these filings to determine the top 15 small-cap stocks held by these elite funds based on 16 years of research that showed their top small-cap picks are much more profitable than both their large-cap stocks and the broader market as a whole. These small-cap stocks beat the S&P 500 Total Return Index by an average of nearly one percentage point per month in our backtests, which were conducted over the period of 1999 to 2012. Moreover, since the beginning of forward testing from August 2012, the strategy worked just as our research predicted, outperforming the market every year and returning 123.1% over the last 34 months, which is more than 66.5 percentage points higher than the returns of the S&P500 ETF (SPY) (see more details).

Insider Monkey also tracks insider trades to deduce the sentiment of insiders in their companies. However, there have been no purchases or sales of shares by insiders of SuperValu this year.

Let’s look at how SuperValu has been traded by hedge funds in the first quarter on the next page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.